In one randomized, cross-over study, 20 participants were given oral glutathione (GSH), sublingual GSH, or NAC for three weeks
The reason this topic receives so much attention is the semaglutide cardiovascular outcomes trial SUSTAIN-6, in which diabetic retinopathy complications were reported more often in the semaglutide group than in the placebo group
Individual results vary enormously based on starting weight, metabolic health, activity level, dietary adherence, and genetic factors
Patients should mark the first-use date on their pen, inspect the solution before each injection, and monitor blood glucose if storage concerns arise
Reduced appetite and rapid weight loss can sometimes lead to emotional side effects like irritability, emotional numbness, or anxiety
Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 based therapies: An expert consensus statement using a modified Delphi approach